| Intrinsic Valuation of: CPRT | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 2 | Market Cap | $31B | |||||
| 2021 | - | - (-) | P/E Ratio | 20 | Total Asset | $10B | |||||
| 2022 | $839M | - (-) | Net Income | $2B | Total Debt | $0 | |||||
| 2023 | $848M | 1.0% (-8.6%) | EBITDA | $2B | Total Liab | $883M | |||||
| 2024 | $962M | 13.5% (3.6%) | Opr Margin | 36.51 | Debt/Equity | - | |||||
| 2025 | $1B | 28.0% (16.7%) | PreTax Margin | 36.51 | BV/Share | 9 | |||||
| 5Y Average FCF | $970M | 11.6% (3.9%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.48% | Historical US Bond Yield: | 4.40% | ||||||||
| Discount Rate (WACC): | 9.09% | Current US Bond Yield: | 3.48% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (11.6%) | ||||||||||
| 2026 | $1B | MBG Intrinsic Value | $14 | ||||||||
| 2027 | $1B | ||||||||||
| 2028 | $2B | ||||||||||
| 2029 | $2B | ||||||||||
| 2030 | $2B | ||||||||||
| 2031 | $2B | ||||||||||
| Terminal Value | $27B | Net Worth/Share | $10 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | $23B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | $3B | $26 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | $0 | WACC | 7.1% | 32 | 34 | 37 | 40 | 45 | |||
| Equity Value | $25B | 8.1% | 27 | 29 | 31 | 33 | 35 | ||||
| Shares Outstanding | 963,308,388 | 9.1% | 24 | 25 | 26 | 28 | 30 | ||||
| 10.1% | 22 | 22 | 23 | 24 | 26 | ||||||
| DCF Intrinsic Value | $26 | 11.1% | 20 | 20 | 21 | 22 | 23 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||